(1)
Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq.” J. Can. Res. Updates 2026, 15 (1), 150-155. https://doi.org/10.30683/1929-2279.2026.15.13.